Drug intelligence / Profile preview

ε-viniferin pentaacetate

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

ε-Viniferin pentaacetate is an **acetylated derivative** of ε-viniferin, a stilbenoid polyphenol and dimer of resveratrol. It is produced as an **intermediate compound** during the synthesis and purification of ε-viniferin from resveratrol. The compound is formed by acetylating crude ε-viniferin-enriched fractions with acetic anhydride and triethylamine in dichloromethane/DMSO, yielding a pentaacetate with five acetyl groups. This acetylation step serves a **purification purpose**, as the acetylated form can be more easily isolated via column chromatography, followed by hydrolysis with potassium hydroxide to regenerate pure ε-viniferin. ε-Viniferin pentaacetate has been studied for its **biological effects**, showing slight reduction in cell proliferation while potentially offering protection from cell degeneration. The parent compound ε-viniferin exhibits diverse biological activities including antibacterial, antibiofilm, antioxidant, and neuroprotective properties. The synthesis method using ruthenium(III) chloride as an oxidizing agent produces ε-viniferin as the major product, which is then converted to its pentaacetate form for purification purposes.

Other names
epsilon-viniferin pentaacetateε-viniferin penta-acetatecompound 6compound6compound-6

Beyond the preview

Go deeper on ε-viniferin pentaacetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ε-viniferin pentaacetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call